The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Research Scholars Program in Hematology/Oncology
The mission of the Gilead Sciences Research Scholars Program in Hematology/Oncology (the "program") is to support innovative scientific research that will advance knowledge in the field of hematology/oncology, with a focus on hematologic malignancies, and provide support for research career development. Gilead Sciences, Inc. hopes that the research supported by these awards will enhance understanding in hematology/oncology.
To that end, grants of up to $130,000 over two years will be awarded to junior faculty researchers for innovative translational research projects in hematology/oncology (with a focus on hematologic malignancies) that can be either based around a clinical trial with strong correlative science or laboratory investigation.
Deadline: September 24, 2020
Applicants must meet the following requirements:
- Hold an MD, DO, PhD, or equivalent degree at time of award
- Be within 5 years of initial faculty appointment in association with an academic research institution in the United States or Canada at the time of application
- Have a strong career interest in hematology/oncology, with a focus on hematologic malignancies
- Have a research mentor with extensive experience in the field of hematology/oncology, with a focus on hematologic malignancies
- Be able to devote at least 50% of professional time to research (versus administrative, patient care, or teaching responsibilities)
- Be able to complete the proposed research within the 2-year award period, providing evidence (manuscript, presentation, or abstracts) for future research projects